800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
SponsoredMethadone Clinics in cities of Delaware
Opioid Use Disorder Treatment Across Delaware
Delaware is compact enough that a person almost anywhere in the state is within reach of medication treatment for opioid use disorder (OUD). This can be through a certified opioid treatment program, an office-based prescriber, or a telehealth visit. Access is most concentrated in New Castle County and Wilmington, with programs in Kent and Sussex as well.
The state runs a coordinated system through the Division of Substance Abuse and Mental Health (DSAMH), including walk-in Bridge Clinics that start treatment quickly. The listings on this page connect you to providers by area; the sections below explain your medication and setting options, what current rules mean for you, and how to pay.
The Three Medications and Where Each is Available
Three medications are approved to treat OUD, and they are dispensed in different settings. Understanding that difference is the key to reading the listings on this page.
Methadone is a full opioid agonist that steadies cravings and withdrawal. For OUD, it is provided only through a licensed opioid treatment program (OTP), not a regular pharmacy, so you receive it on-site at a certified clinic.
Buprenorphine, including the buprenorphine-naloxone combination sold as Suboxone and the extended-release monthly injection Sublocade, is a partial agonist with a built-in ceiling that lowers overdose risk. Since a 2023 federal change, any clinician with a standard DEA registration can prescribe it, so you can get it in a doctor’s office or Bridge Clinic and fill it at a pharmacy, or receive it inside an OTP.
Naltrexone, including the monthly Vivitrol injection, is not an opioid at all; it blocks opioid effects. Any licensed prescriber can order it, but treatment starts only after you have been off opioids for a set time, so a clinician plans the timing with you.
No single medication is right for everyone, and which one fits is a decision you make with a provider. If you want a fuller side-by-side, see how methadone and Suboxone compare, more detail on how methadone treatment works, and what to expect from an opioid treatment program.
State Rules, Coverage and Funding in Delaware
Delaware layers its own system on top of the federal baseline, and in several ways it has moved ahead of it. DSAMH, part of the Department of Health and Social Services, oversees treatment programs statewide and operates Bridge Clinics that offer same-day or next-day buprenorphine along with assessment, counseling, peer support and a warm handoff to longer-term care.
Delaware was also the first state to let paramedics initiate buprenorphine in the field. Under an EMS standing order in place statewide since April 2023, people treated for an opioid overdose can be offered buprenorphine on the spot and a route into treatment.
Cost is often the first worry, so start here. One option is Delaware’s Medicaid program, the Diamond State Health Plan, which covers all three FDA-approved medications and is delivered through managed care organizations. For people who are uninsured or underinsured, DSAMH provides state-funded coverage so that screening, intake, counseling and medication are available regardless of ability to pay.
Federal rules updated in 2024 also expanded take-home methadone (up to a 28-day supply for patients who are stable in treatment, as decided by the program), allowed treatment to begin by telehealth, and removed older admission barriers. As of 2026, buprenorphine can be started through telehealth, including by phone and in many cases, without a prior in-person visit. These flexibilities run through the end of 2026 and are still being finalized, so confirm current options with a provider.
Methadone for OUD remains dispensed through an OTP. If keeping treatment steady through a job or a move is a concern, it helps to know why a consistent methadone dose matters and how treatment interacts with work and privacy.
The Overdose Picture, and Why Treatment is the Response
Delaware has recorded real progress. Confirmed drug overdose deaths fell from 527 in 2023 to 338 in 2024, a decline of nearly 36 percent, according to the Division of Forensic Science and DHSS. These numbers are outpacing the national drop of about 26.5 percent over a comparable period. State officials credit the decline to wider naloxone distribution, expanded treatment access and public health outreach.
Deaths and emergency visits have been most concentrated in Wilmington and New Castle County, where fentanyl remains the dominant driver. The drug was present in more than 80 percent of accidental overdose deaths in recent years, and xylazine and other adulterants continue to complicate the drug supply.
The takeaway for anyone reading this is straightforward: medication treatment reduces the risk of fatal overdose and is available across the state right now. For background on the condition itself, see this overview of opioid addiction and how it is treated.
Starting Treatment and Finding a Program Near You
Getting started usually begins with an assessment, either at a DSAMH Bridge Clinic or directly with a program listed on this page. That visit reviews your history and helps match you to a medication and setting. Buprenorphine can often begin the same or next day through a Bridge Clinic; methadone begins at an OTP, and some programs can start the process with a telehealth visit.
If you have been using fentanyl, timing the first buprenorphine dose matters, because starting too soon can trigger sudden, severe withdrawal (precipitated withdrawal), so a clinician plans that step with you.
Most treatment here is outpatient, though residential and inpatient options exist for some situations; you can read about opioid addiction treatment settings and, if relevant, inpatient care. To take the next step, use the listings on this page to reach a provider in your county, or call the helpline for help finding one.
Pregnancy, Reentry and Other Specific Situations
For pregnant patients, methadone and buprenorphine are the recommended standard of care. Treatment protects both parent and baby; because left untreated, OUD carries a great risk for them both. Neonatal opioid withdrawal syndrome (NOWS) is manageable and expected, and care teams plan for it.
Unfortunately, fear of child welfare involvement keeps some pregnant Delawareans from seeking care, so it helps to know that starting treatment is what clinical guidance recommends. To help support pregnant people, Delaware’s perinatal outreach includes mobile health teams such as Beebe Healthcare’s community program in Sussex County, which connects people to treatment and resources.
For people leaving incarceration, continuity of medication is critical in the high-risk weeks after release and many reentry pathways aim to keep treatment uninterrupted.
Families supporting someone through any of this will find practical guidance in this resource for families and more on methadone and pregnancy.
Naloxone and Overdose Safety in Delaware
Naloxone, the medication that reverses an opioid overdose, is easy to get in Delaware and everyone close to opioid use should keep it on hand. It is sold over the counter without a prescription at participating pharmacies, including CVS, Walmart and Sam’s Club locations statewide. Additionally, the Division of Public Health partners with NEXT Distro to mail it free to residents who cannot access it in person.
Furthermore, the state’s Opioid Antagonist Access Program supports standing-order distribution, and harm-reduction vending machines around the state stock naloxone along with fentanyl and xylazine test strips.
A return to use is a common, manageable part of recovery rather than a failure, and naloxone is a safeguard for exactly those moments. Learn more about recognizing and responding to a methadone or opioid overdose.
In some cases, fear of prosecution keeps an individual from calling 9-1-1 in overdose situations; this can mean the difference between life and death. Delaware’s Good Samaritan law offers protection for helpers from low-level drug offenses and grants civil immunity to those who administer naloxone.
Common Questions About MOUD in Delaware
Is methadone available at a pharmacy in Delaware?
No. Methadone for opioid use disorder is dispensed only through a licensed opioid treatment program, where you receive it on-site. Buprenorphine and naltrexone are different: a clinician can prescribe them in an office or Bridge Clinic and you fill them at a pharmacy.
Can I start Suboxone by telehealth in Delaware?
In most cases, yes. As of 2026, buprenorphine can be started through telehealth, including by phone in many situations, without a prior in-person visit. These federal flexibilities run through the end of 2026 and are still being finalized, so be sure to confirm what is current with the provider before you make contact.
Will Medicaid cover my treatment?
Delaware’s Medicaid program, the Diamond State Health Plan, covers all three approved medications through its managed care organizations. If you are uninsured, DSAMH offers state-funded coverage so cost does not have to be a barrier. Ask any program on this page what it accepts.
How fast can I get in?
DSAMH Bridge Clinics are built for speed and can often start buprenorphine the same or next day after an assessment. Methadone begins through an opioid treatment program, and some programs can start the process with a telehealth visit. Wait times vary by provider, so calling more than one is reasonable.
What is the difference between a clinic and office-based treatment?
An opioid treatment program (OTP) dispenses methadone on-site and can also provide buprenorphine and naltrexone, often with counseling built in. Office-based treatment means a prescriber writes for buprenorphine or naltrexone that you fill at a pharmacy.
Both are legitimate treatment options. The right fit depends on your medication and how much structure helps you. You can also read whether it is possible to become dependent on methadone and how that differs from active addiction.
Last reviewed and disclosures
Last reviewed July 2026.
Sources: Delaware DHSS, DSAMH, and Division of Forensic Science, 2024 overdose deaths (2025); DSAMH, Help Is Here Delaware, Medication for Opioid Use Disorder and Bridge Clinics; Delaware EMS statewide buprenorphine standing order (2023); DSAMH, Help Is Here Delaware, Overdose Prevention and Good Samaritan Law; Delaware Code Title 16, Chapter 30G, Opioid Antagonist Access Program; SAMHSA and DEA, buprenorphine telemedicine rule (2025 to 2026); SAMHSA, 42 CFR Part 8 revisions (2024).
Methadone Centers is a treatment-discovery and education platform, not a medical provider. We do not provide medical advice, diagnosis, or treatment. Always consult a qualified clinician about your care.
The helpline on this site is a sponsored resource. Calls may be answered by a paid advertiser. Using it is not required to access any provider listed on this page.